七次分割部分乳腺照射:毒性低
这项II期试验评估了早期乳腺癌患者接受35 Gy/7次(5 Gy/次)外照射部分乳腺照射的毒性和临床结局。5年局部控制率和无远处转移生存率分别为98%和96.7%,美容效果良好/优秀占93%。
要点
- 35 Gy/7次(5 Gy/次)外照射部分乳腺照射未记录到3级毒性。
- 2级疼痛、2级纤维化和无症状脂肪坏死发生率分别为2.7%、6.7%和5%。
- 5年局部控制率98%,无远处转移生存率96.7%,美容效果良好/优秀93%。
核心结论
- 35 Gy分7次每日照射是部分乳腺照射中有效且耐受性良好的方案。
主要发现
- 未记录到3级毒性;2例(2.7%)在部分乳腺照射后6个月出现2级疼痛,4例(5%)出现无症状脂肪坏死,5例(6.7%)出现2级纤维化。
- 早期和晚期毒性均与辅助全身治疗类型(无治疗 vs 内分泌治疗 vs 化疗)无关,也未发现剂量学参数与毒性之间的统计学相关性。
- 发生2级放射性纤维化的患者未照射正常乳腺的照射体积并不高于无纤维化者。
- 多数病例美容效果评为良好/优秀(93%);1例局部复发、1例远处转移,对应5年局部控制率98%、无远处转移生存率96.7%。
关键数值与推荐
- 部分乳腺照射剂量方案为35 Gy分7次,每次5 Gy,每日照射。
- 入组条件为60岁及以上、早期浸润性癌且接受保乳手术。
- 5年局部控制率98%,5年无远处转移生存率96.7%,美容效果良好/优秀率93%。
临床怎么用
- 对于60岁及以上保乳术后早期乳腺癌患者,可考虑35 Gy/7次的外照射部分乳腺照射方案。
- 该方案毒性低,但需关注2级疼痛、纤维化和无症状脂肪坏死。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess toxicity and clinical outcome, in breast cancer patients treated with external beam partial breast irradiation (PBI) consisting of 35 Gy in 7 daily fractions (5 Gy/fraction). MATERIALS AND METHODS: Patients affected by early-stage breast cancer were enrolled in this phase II trial. Patients had to be 60 years old or over and treated with breast conservative surgery for early stage invasive carcinoma. RESULTS: Seventy-three patients were analyzed. Median follow-up was 40 months. The proposed schedule was well tolerated. No Grade 3 toxicity was documented. Late toxicity was assessable for all the treated patients. Two patients (2.7%) developed Grade 2 pain 6 months after PBI. Four patients (5%) developed asymptomatic fat necrosis. Grade 2 fibrosis was observed in 5 patients (6.7%). No correlation was found between early and late toxicity and the type of adjuvant systemic therapy (no therapy vs. hormonal therapy vs. chemotherapy). No statistical correlation between dosimetric parameters and toxicity was found. Patients who developed Grade 2 radiation fibrosis had not higher radiation volumes to the untreated normal breast than those without fibrosis. Cosmesis was judged good/excellent in the majority of the cases (93%). One patient relapsed locally, and one developed distant metastases, corresponding to a 5-year local control and distant metastases-free survival of 98% and 96.7%, respectively. CONCLUSIONS: 35 Gy in 7 daily fractions is an effective and well-tolerated regimen to deliver PBI.
引用
- Trovo M, Avanzo M, Vinante L, et al. Seven fractions to deliver partial breast irradiation: the toxicity is Low. Radiat Oncol. 2017. PMID: 28535821. doi:10.1186/s13014-017-0825-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。